Ascendis Pharma Stock (NASDAQ: ASND) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 0 / 350.824K |
Day Range | - - - |
52 Wk Range | 66.030 - 161.000 |
Market Cap | $8.199B |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 48 |
Short Interest | 8.52% |
Days to Cover | 11.64 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Ascendis Pharma (NASDAQ: ASND) through any online brokerage.
Other companies in Ascendis Pharma’s space includes: Legend Biotech (NASDAQ:LEGN), Exact Sciences (NASDAQ:EXAS), Sarepta Therapeutics (NASDAQ:SRPT), Neurocrine Biosciences (NASDAQ:NBIX) and Cerevel Therapeutics Hldg (NASDAQ:CERE).
The latest price target for Ascendis Pharma (NASDAQ: ASND) was reported by Morgan Stanley on Monday, April 22, 2024. The analyst firm set a price target for 116.00 expecting ASND to fall to within 12 months (a possible -19.91% downside). 35 analyst firms have reported ratings in the last year.
The stock price for Ascendis Pharma (NASDAQ: ASND) is $144.83 last updated April 23, 2024 at 4:00 PM EDT.
There are no upcoming dividends for Ascendis Pharma.
Ascendis Pharma’s Q1 earnings are confirmed for Tuesday, May 7, 2024.
There is no upcoming split for Ascendis Pharma.
Ascendis Pharma is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.